Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: A controlled investigation

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 5, 2009, Pages 226-230

  Ruffini, Chiara ^a   Locatelli, Marco ^a   Lucca, Adelio ^a   Benedetti, Francesco ^a   Insacco, Chiara ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956403639     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08m00663     Document Type: Article

References (32)

1. Karno M, Golding JM, Sorenson SB, et al. The epidemiology of obsessive compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45(12):1094-1099.
2. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1994;55(suppl):5-10.
3. Pallanti S, Hollander E, Bienstock C, et al. Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5(2):181-191.
4. Albert U, Bergesio C, Pessina E, et al. Management of treatment resistant obsessive-compulsive disorder: algorithms for pharmacotherapy. Panminerva Med. 2002;44(2):83-91.
5. Ipser JC, Carey P, Dhansay Y, et al. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev. 2006;(4):CD005473.
6. Husain FT, Nandipati G, Braun AR. Stimulating transcranial magnetic stimulation during PET with a large-scale neural network model of the prefrontal cortex and the visual system. Neuroimage. 2002;15(1):58-73.
7. Mantovani A, Lisanby SH, Pieraccini F, et al. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol. 2006;9(1):95-100.
8. Martin JL, Barbanoj MJ, Pérez V, et al. Transcranial magnetic stimulation for treatment of obsessive-compulsive disorder. Cochrane Database Syst Rev. 2003;(3):CD003387.
9. Greenberg BD, George MS, Artin JD, et al. Effect of prefrontal transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry. 1997;154(6):867-869.
10. Alonso P, Pujol J, Cardoner N, et al. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double blind, placebo-controlled study. Am J Psychiatry. 2001; 158(7):1143-1145.
11. Sachdev PS, Mc Bride R, Loo CK, et al. Right versus left prefrontal transcranial stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry. 2001;62(12):981-984.
12. Prasko J, Pasková B, Zálesky ́ R, et al. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive-compulsive disorder: a randomized, double-lind, sham-controlled study. Neuroendocrinol Lett. 2006;27(3):327-332.
13. Sachdev PS, Loo CK, Mitchell PB, et al. Repetitive transcranial magnetic stimulation for the treatment of obsessive-ompulsive disorder: a double-blind controlled investigation. Psychol Med. 2007;37(11):1645-1649.
14. Baxter LR, Schwartz JM, Mazziotta JC, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry. 1988;145(12):1560-1563.
15. Rubin RT, Villanueva-Meyer J, Ananth J, et al. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects: determination by high-resolution single-photon emission computed tomography. Arch Gen Psychiatry. 1992;49(9):695-702.
16. 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol Psychiatry. 1995;38(7):429-437.
17. Alptekin K, Degermenci B, Kivircik B, et al. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression. Psychiatry Res. 2001;107(1):51-56.
18. Molina V, Montz R, Martin-Loeches M, et al. Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med. 1995;36(12):2234-2238.
19. Baxter LR, Phelos ME, Mazziotta JC, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls.Arch Gen Psychiatry. 1987;44(3):211-218.
20. Swedo SE, Schapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1989;46(6):518-523.
21. van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry. 2005;62(3):301-309.
22. Remijnse PL, Nielen MM, van Balkom AJ, et al. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63(11): 1225-1236.
23. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1-16.
24. Saghaei M. Random allocation software for parallel group randomized trials. BMC Med Res Methodol. 2004;4:26.
25. Pridmore S, Fernandes Filho JA, Nahas Z, et al. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. J ECT. 1998;14(1):25-27.
26. Okamoto M, Dan H, Sokamto K, et al. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping. Neuroimage. 2004;21(1):99-111.
27. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011.
28. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry. 1989;46(11):1012-1016.
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
30. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55.
31. Lipsman N, Neimat JS, Lozano AM. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target. Neurosurgery. 2007;61(1):1-11.
32. Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet. 1999;354(9189):1526.